Santa Monica-Ucla Pathology is categorized under Doctors in Santa Monica, CA and active since 2001.
Santa Monica-Ucla Pathology was established in 2001, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Geri Goodeliunas, Office Manager at the company’s single location by writing to 1250 16th St, Santa Monica, California CA 90404 or by phoning (310) 319-4514. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Santa Monica-Ucla Pathology |
Contact Person: | Geri Goodeliunas, Office Manager |
Address: | 1250 16th St, Santa Monica, California 90404 |
Phone Number: | (310) 319-4514 |
Website Address: | uclahealth.org |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Santa Monica-Ucla Pathology was started in 2001 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Geri Goodeliunas, Office Manager for inquiries that concern Santa Monica-Ucla Pathology by calling the company number (310) 319-4514, as your correspondence is most welcome. Additionally, the physical location of the single location of Santa Monica-Ucla Pathology can be found at the coordinates 34.02744,-118.48599 as well as the street address 1250 16th St in Santa Monica, California 90404.
For its online presence, you may visit Santa Monica-Ucla Pathology’s website at uclahealth.org and engage with its social media outlets through on Twitter and on Facebook.